IL10 and stroke disorder: A study where bone marrow-derived mesenchymal stem cells were transplanted into the lateral ventricle of Sprague-Dawley rats before pMCAO yielded similar results, where IL-10 mRNA and protein levels were elevated 4 days post-stroke, TNFα was reduced, infarct size was smaller, and neurologic function was improved (101).